While it's their job to combat drug smuggling and coinciding usage within the United States, the Drug Enforcement Administration (DEA) will soon up the amount of marijuana that can legally be grown in the U.S. for research purposes exponentially, from around 1,000 pounds in 2018 to more than 5,400 pounds next year, Forbes reports. According to the publication, a new Federal Register filing will be published in the near future, detailing the DEA's plans for 2019.

In addition, the administration is aiming to cut down on opioid production, including oxycodone, hydrocodone, morphine, and fentanyl.

“We’ve lost too many lives to the opioid epidemic and families and communities suffer tragic consequences every day,” Uttam Dhillon, DEA Acting Administrator, noted in a recent press release. “This significant drop in prescriptions by doctors and DEA’s production quota adjustment will continue to reduce the amount of drugs available for illicit diversion and abuse while ensuring that patients will continue to have access to proper medicine.”

The DEA went on to add that quotas for cannabis and other drugs "reflects the total amount of controlled substances necessary to meet the country’s medical, scientific, research, industrial, and export needs for the year and for the establishment and maintenance of reserve stocks."

The organization is also proposing to keep the production of tetrahydrocannabinols (THC) at 384,460 grams in 2019, the same amount as this year.

The DEA's quotas for 2019 have yet to officially appear in the Federal Register, but once they do, the public can then submit comments pertaining to the proposal for the following 30 days, then allowing the DEA to make amends if they choose to do so.

For more on the DEA's drug proposals for 2019, visit Forbes.

Next, watch our ‘High End’ documentary on luxury weed.

What To Read Next

  • Image on Highsnobiety

    Zooming in on Louis Vuitton's First Runway Show Without Virgil

    Style
  • Image on Highsnobiety

    Debunking Fragrance in Skincare Myths With Dr. Z

  • Image on Highsnobiety

    Unpacking The Ordinary's “Skinification of Hair”

  • Image on Highsnobiety

    Therabody's TheraFace Is a Mini Massage Gun for Better Skin

    Culture
  • Image on Highsnobiety

    Bored Ape NFTs Have Entered the Beauty Chat

  • Image on Highsnobiety

    Bobbi Brown & Jones Road Made an Expletive-Inducing Foundation

    Culture
*If you submitted your e-mail address and placed an order, we may use your e-mail address to inform you regularly about similar products without prior explicit consent. You can object to the use of your e-mail address for this purpose at any time without incurring any costs other than the transmission costs according to the basic tariffs. Each newsletter contains an unsubscribe link. Alternatively, you can object to receiving the newsletter at any time by sending an e-mail to info@highsnobiety.com

Web Accessibility Statement

Titelmedia (Highsnobiety), is committed to facilitating and improving the accessibility and usability of its Website, www.highsnobiety.com. Titelmedia strives to ensure that its Website services and content are accessible to persons with disabilities including users of screen reader technology. To accomplish this, Titelmedia has engaged UsableNet Inc, a leading web accessibility consultant to help test, remediate and maintain our Website in-line with the Web Content Accessibility Guidelines (WCAG), which also bring the Website into conformance with the Americans with Disabilities Act of 1990.

Disclaimer

Please be aware that our efforts to maintain accessibility and usability are ongoing. While we strive to make the Website as accessible as possible some issues can be encountered by different assistive technology as the range of assistive technology is wide and varied.

Contact Us

If, at any time, you have specific questions or concerns about the accessibility of any particular webpage on this Website, please contact us at accessibility@highsnobiety.com, +49 (0)30 235 908 500. If you do encounter an accessibility issue, please be sure to specify the web page and nature of the issue in your email and/or phone call, and we will make all reasonable efforts to make that page or the information contained therein accessible for you.